Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

Esther Kissling, on behalf of I-MOVE-COVID- and ECDC primary care study teams, Simon de Lusignan(University of Oxford), Mariëtte Hooiveld(Netherlands Institute for Health Services Research), Mihaela Lazăr, Lisa Domegan(Health Service Executive), Shirley Masse(Inserm), Chris Robertson(University of Strathclyde), Marta Valenciano(World Health Organization), Lucia Pastore Celentano(European Centre for Disease Prevention and Control), Susana Monge(Instituto de Salud Carlos III), Naoma William(Public Health Scotland), Gloria Pérez‐Gimeno(Instituto de Salud Carlos III), Luca Basile(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Ana Paula Rodrigues(Microsoft (Brazil)), Vincent Enouf(Université Claude Bernard Lyon 1), Niel Hens(University of Antwerp), Adam Meijer(National Centre for Infectious Diseases), Itziar Casado(Instituto de Salud Carlos III), Philippe Beutels(Infectious Diseases Institute), Sabrina Bacci(European Centre for Disease Prevention and Control), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Angela Rose, Alain Moren(Health Service Executive), Neus Latorre‐Margalef(Public Health Agency of Sweden), Maximilian Rieß(Paul Ehrlich Institut), Theresa Enkirch(Public Health Agency of Sweden), Joan O’Donnell(Health Service Executive), Mirjam J. Knol(National Institute for Public Health and the Environment), Noémie Sève(Inserm), Iván Martínez‐Baz(Instituto de Salud Carlos III), Maja Ilić(Hrvatski zavod za javno zdravstvo), Mark Hamilton(Public Health Scotland), Raquel Guiomar(National Institute of Health Dr. Ricardo Jorge), Adele McKenna(Health Protection Surveillance Centre), Heather Whitaker(Public Health Agency of Canada), Olivia-Carmen Timnea(Institutul Cantacuzino), Ivan Mlinarić(Hrvatski zavod za javno zdravstvo)
American Journal of Epidemiology
November 15, 2025
Cited by 0


Related Papers